TNX-4800 is a long-acting anti-Borrelia burgdorferi OspA human monoclonal antibody in development as a single-dose Lyme prophylactic Phase 1 ...
Company expects to initiate a randomized, double-blind, placebo-controlled, adaptive Phase 2 field study in the first half of 2027, pending FDA clearance BERKELEY HEIGHTS, N.J., March 31, 2026 (GLOBE ...
Objective To evaluate the impact of an Australian Virtual Care service on low-acuity patient presentations to emergency departments (EDs) across a local health district. Design This was a ...
The crucial utilities sector is getting a boost from A.I. data centers, and VPU is capitalizing on it while delivering solid ...
I’ve read a bunch of books on data literacy over the years. I’m a data person, so I get data, but I find reading data ...
Paragonix Technologies will feature oral presentations and poster sessions at ISHLT 2026, showcasing clinical data related to its heart and lung ...
A detailed breakdown of the cost of buying and selling a home in 2026, including fees, taxes, insurance, and expenses buyers ...
The lender claims an originator ambushed executives in a negotiation with the confidential company financials and claimed to ...
Two weeks after rejecting an initial plan, the Jefferson County Board of Education approved revised cuts to JCPS' special ...
Paragonix Technologies will feature oral presentations and poster sessions at ISHLT 2026, showcasing clinical data related to its heart and lung preservation devices.The extensive research being prese ...
Ingredient-level intelligence is redefining beauty e-commerce—turning product data into AI-ready insights that drive ...
Discusses Topline Results From Lowest Dose MAD Cohort in Phase II FREEDOM2 Study With Favorable Safety, Splicing and vHOT Data March ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results